VPHIF OTC
Valeo Pharma Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -0.0%
1Y: -99.8%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$41M
-29.3% ▼
5Y CAGR: +64.8%
Total Liabilities
$82M
+7.1% ▲
5Y CAGR: +76.6%
Shareholders Equity
-$40M
-126.0% ▼
Cash & Investments
$8M
-66.7% ▼
5Y CAGR: +265.7%
Total Debt
$65M
+6.1% ▲
5Y CAGR: +93.4%
Net Debt
$58M
+48.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $335K | $3M | $2M | $23M | $8M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $335K | $3M | $2M | $23M | $8M |
| Net Receivables | $448K | $1M | $1M | $5M | $7M |
| Inventory | $561K | $881K | $8M | $10M | $10M |
| Other Current Assets | $165K | $211K | $324K | $2M | $0 |
| Total Current Assets | $2M | $5M | $12M | $41M | $25M |
| Property, Plant & Equip. | $296K | $605K | $2M | $2M | $3M |
| Goodwill & Intangibles | $4M | $5M | $7M | $15M | $12M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $2M |
| Total Non-Current Assets | $4M | $6M | $9M | $18M | $16M |
| Total Assets | $6M | $11M | $21M | $58M | $41M |
| — Liabilities — | |||||
| Accounts Payable | $4M | $3M | $7M | $4M | $4M |
| Short-Term Debt | $0 | $0 | $5M | $743K | $5M |
| Deferred Revenue | $0 | $0 | $0 | $10M | $0 |
| Other Current Liabilities | $598K | $719K | $3M | -$1M | $9M |
| Total Current Liabilities | $4M | $4M | $15M | $15M | $20M |
| Long-Term Debt | $1M | $3M | $2M | $60M | $59M |
| Other Non-Current Liab. | $351K | $416K | $873K | $127K | $771K |
| Total Non-Current Liabilities | $1M | $4M | $4M | $61M | $61M |
| Total Liabilities | $6M | $8M | $19M | $76M | $82M |
| — Equity — | |||||
| Common Stock | $9M | $15M | $25M | $26M | $32M |
| Retained Earnings | -$10M | -$14M | -$29M | -$54M | -$82M |
| Accumulated OCI | -$325K | -$422K | -$319K | -$201K | -$307K |
| Total Stockholders Equity | -$22K | $3M | $2M | -$18M | -$40M |
| Total Liabilities & Equity | $6M | $11M | $21M | $58M | $41M |
| — Key Metrics — | |||||
| Total Debt | $1M | $3M | $8M | $61M | $65M |
| Net Debt | $666K | $426K | $6M | $39M | $58M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |